Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

Current progress in medical mycology / Héctor M. Mora-Montes, Leila M. Lopes-Bezerra, editors.

Contributor(s): Lopes-Bezerra, Leila M.,, editor literario | Mora-Montes, Hector Manuel,, editor literario
Material type: materialTypeLabelE-bookPublisher: Cham, Switzerland : Springer International Publishing, 2017Copyright date: 2017Description: 1 recurso en línea : ilustraciones.ISBN: 3319641131; 9783319641133.Subject: Micología médicaOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
""Preface""; ""Contents""; ""Contributors""; ""Chapter 1: Introduction to Medical Mycology""; ""1.1 Definition and Structure""; ""1.2 Emergence of Challenge Due to Fungal Infections""; ""1.3 Spectrum of Fungal Infections""; ""1.3.1 Superficial Mycoses""; ""1.3.2 Invasive/Opportunistic Mycoses""; ""1.3.3 Endemic Mycoses""; ""1.3.4 Allergic Manifestations""; ""1.4 Classification""; ""1.5 Epidemiology of Fungal Infections""; ""1.5.1 Global Burden of Disease""; ""1.5.2 Predisposing Factors for Fungal Infections""; ""1.5.3 Geographical Distribution""
""1.5.4 Community Acquired Fungal Infections""""1.5.5 Nosocomial Fungal Infections""; ""1.6 Fungal Infection Immunity and Pathogenesis""; ""1.6.1 Innate Immunity""; ""1.6.2 Adaptive Immunity""; ""1.6.3 Fungal Virulence""; ""1.6.4 Tissue Reaction""; ""1.7 Diagnosis of Fungal Infections""; ""1.7.1 Radiological Imaging""; ""1.7.2 Conventional and Culture Based Diagnosis""; ""1.7.3 Sepsis Biomarkers""; ""1.7.4 Serology""; ""1.7.5 Molecular Detection""; ""1.8 Treatment""; ""1.9 Fungal Vaccines""; ""References""; ""Chapter 2: Antifungal Drugs""
""2.1 Polyenes (Amphotericin B Deoxycholate and Its Lipid-­Associated Formulations)""""2.1.1 Amphotericin B Deoxicholate""; ""2.1.1.1 Chemical Structure""; ""2.1.1.2 Mechanism of Action""; ""2.1.1.3 Pharmacokinetics and Pharmacodynamics""; ""2.1.1.4 Spectrum of Activities and Resistance""; ""2.1.1.5 Clinical Uses""; ""2.1.1.6 Dosing""; ""2.1.1.7 Adverse Events and Toxicity""; ""2.1.1.8 Contraindication""; ""2.1.1.9 Drug Interactions""; ""2.1.1.10 Use in Special Population""; ""2.1.2 Lipid Formulations of Amphotericin B""; ""2.1.2.1 Dosing""; ""2.1.2.2 Adverse Events and Toxicity""
""2.2 Triazole Antifungal Agents""""2.2.1 General Properties""; ""2.2.1.1 Chemical Structure""; ""2.2.1.2 Mechanism of Action""; ""2.2.1.3 Pharmacokinetics""; ""2.2.1.4 Spectrum of Activity and Resistance""; ""2.2.1.5 Clinical Utility""; ""2.2.1.6 Adverse Events and Drug Interactions""; ""2.2.1.7 Dosing and Administration. Use in Special Populations""; ""2.2.2 Individual Agents""; ""2.2.2.1 Itraconazole""; ""2.2.2.2 Fluconazole""; ""2.2.2.3 Voriconazole""; ""2.2.2.4 Posaconazole""; ""2.2.2.5 Isavuconazole""
""2.2.3 Newer and Investigational Agents: Efinaconazole, Albaconazole, Ravuconazole and Others""""2.3 Echinocandins""; ""2.3.1 Chemical Structure""; ""2.3.2 Mechanism of Action""; ""2.3.3 Pharmacokinetics and Pharmacodynamics""; ""2.3.4 Spectrum of Activity and Resistance""; ""2.3.5 Clinical Uses""; ""2.3.6 Adverse Events and Toxicity""; ""2.3.7 Drug Interactions""; ""2.3.8 Use in Special Population and Dose Adjustments""; ""2.3.9 Adult Dosing""; ""2.3.10 New Echinocandin""; ""2.4 Flucytosine""; ""2.4.1 Chemical Structure""; ""2.4.2 Mechanism of Action""
Abstract: Infections caused by fungi have recently attracted the attention of both clinicians and basic researchers given the heavy burden they represent for any health system. The mortality and morbidity rates associated to mycosis are progressively rising simply because some of these diseases are still neglected by health-care workers and due to the changing sensitivity to antifungal drugs displayed by these organisms. In this book, both researchers and clinicians working in the medical mycology field explore the most recent literature about specific mycosis; placing in one concise chapter thoroughly revisions of the current knowledge on virulence factors, recognition by immune cells, immunoevasion, epidemiology, new diagnosis trends and therapeutics. This book is recommended to researchers, physicians and students interested in medical mycology.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud QR245 .L67 2017 EB (Browse shelf(Opens below)) Acceso electrónico eBook.20024253
Total holds: 0

Incluye referencias bibliográficas

""Preface""; ""Contents""; ""Contributors""; ""Chapter 1: Introduction to Medical Mycology""; ""1.1 Definition and Structure""; ""1.2 Emergence of Challenge Due to Fungal Infections""; ""1.3 Spectrum of Fungal Infections""; ""1.3.1 Superficial Mycoses""; ""1.3.2 Invasive/Opportunistic Mycoses""; ""1.3.3 Endemic Mycoses""; ""1.3.4 Allergic Manifestations""; ""1.4 Classification""; ""1.5 Epidemiology of Fungal Infections""; ""1.5.1 Global Burden of Disease""; ""1.5.2 Predisposing Factors for Fungal Infections""; ""1.5.3 Geographical Distribution""

""1.5.4 Community Acquired Fungal Infections""""1.5.5 Nosocomial Fungal Infections""; ""1.6 Fungal Infection Immunity and Pathogenesis""; ""1.6.1 Innate Immunity""; ""1.6.2 Adaptive Immunity""; ""1.6.3 Fungal Virulence""; ""1.6.4 Tissue Reaction""; ""1.7 Diagnosis of Fungal Infections""; ""1.7.1 Radiological Imaging""; ""1.7.2 Conventional and Culture Based Diagnosis""; ""1.7.3 Sepsis Biomarkers""; ""1.7.4 Serology""; ""1.7.5 Molecular Detection""; ""1.8 Treatment""; ""1.9 Fungal Vaccines""; ""References""; ""Chapter 2: Antifungal Drugs""

""2.1 Polyenes (Amphotericin B Deoxycholate and Its Lipid-­Associated Formulations)""""2.1.1 Amphotericin B Deoxicholate""; ""2.1.1.1 Chemical Structure""; ""2.1.1.2 Mechanism of Action""; ""2.1.1.3 Pharmacokinetics and Pharmacodynamics""; ""2.1.1.4 Spectrum of Activities and Resistance""; ""2.1.1.5 Clinical Uses""; ""2.1.1.6 Dosing""; ""2.1.1.7 Adverse Events and Toxicity""; ""2.1.1.8 Contraindication""; ""2.1.1.9 Drug Interactions""; ""2.1.1.10 Use in Special Population""; ""2.1.2 Lipid Formulations of Amphotericin B""; ""2.1.2.1 Dosing""; ""2.1.2.2 Adverse Events and Toxicity""

""2.2 Triazole Antifungal Agents""""2.2.1 General Properties""; ""2.2.1.1 Chemical Structure""; ""2.2.1.2 Mechanism of Action""; ""2.2.1.3 Pharmacokinetics""; ""2.2.1.4 Spectrum of Activity and Resistance""; ""2.2.1.5 Clinical Utility""; ""2.2.1.6 Adverse Events and Drug Interactions""; ""2.2.1.7 Dosing and Administration. Use in Special Populations""; ""2.2.2 Individual Agents""; ""2.2.2.1 Itraconazole""; ""2.2.2.2 Fluconazole""; ""2.2.2.3 Voriconazole""; ""2.2.2.4 Posaconazole""; ""2.2.2.5 Isavuconazole""

""2.2.3 Newer and Investigational Agents: Efinaconazole, Albaconazole, Ravuconazole and Others""""2.3 Echinocandins""; ""2.3.1 Chemical Structure""; ""2.3.2 Mechanism of Action""; ""2.3.3 Pharmacokinetics and Pharmacodynamics""; ""2.3.4 Spectrum of Activity and Resistance""; ""2.3.5 Clinical Uses""; ""2.3.6 Adverse Events and Toxicity""; ""2.3.7 Drug Interactions""; ""2.3.8 Use in Special Population and Dose Adjustments""; ""2.3.9 Adult Dosing""; ""2.3.10 New Echinocandin""; ""2.4 Flucytosine""; ""2.4.1 Chemical Structure""; ""2.4.2 Mechanism of Action""

Infections caused by fungi have recently attracted the attention of both clinicians and basic researchers given the heavy burden they represent for any health system. The mortality and morbidity rates associated to mycosis are progressively rising simply because some of these diseases are still neglected by health-care workers and due to the changing sensitivity to antifungal drugs displayed by these organisms. In this book, both researchers and clinicians working in the medical mycology field explore the most recent literature about specific mycosis; placing in one concise chapter thoroughly revisions of the current knowledge on virulence factors, recognition by immune cells, immunoevasion, epidemiology, new diagnosis trends and therapeutics. This book is recommended to researchers, physicians and students interested in medical mycology.

There are no comments on this title.

to post a comment.
Share